The genome-wide pan-cancer analysis is advantageous for elucidating the correlation between the expression of CX3CL1 and carcinogenesis, which in turn informs the development of more effective surveillance, diagnosis, and treatment strategies. The gene discussed is CX3CL1; the disease is cancer.